Wellington Management Group Llp Cuts Stake in PTC Therapeutics ... - Nasdaq
| FBIOX Fund | USD 20.50 0.29 1.39% |
Slightly above 62% of Biotechnology Portfolio's investor base is looking to short. The analysis of overall sentiment of trading Biotechnology Portfolio Biotechnology mutual fund suggests that many investors are alarmed at this time. Biotechnology Portfolio's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Portfolio's earnings reports, geopolitical events, and overall market trends.
Biotechnology |
Wellington Management Group Llp Cuts Stake in PTC Therapeutics ... Nasdaq
Read at news.google.com
 |
Biotechnology Portfolio Fundamental Analysis
We analyze Biotechnology Portfolio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Biotechnology Portfolio is currently under evaluation in price to sales among similar funds. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Biotechnology Portfolio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Portfolio mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Portfolio could also be used in its relative valuation, which is a method of valuing Biotechnology Portfolio by comparing valuation metrics with similar companies.
Peers
Biotechnology Portfolio Related Equities
| FBSOX | It Services | 0.66 | ||||
| FSCSX | Software And | 0.16 | ||||
| FSPHX | Health Care | 0.19 | ||||
| FSELX | Fidelity Select | 0.20 | ||||
| FSPTX | Technology Portfolio | 0.33 |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |